Keynote speaker
We are pleased to welcome Hugh Marston, Germany, as the keynote speaker.
The title of his keynote lecture will be announced soon.
From signals to stratification: building evidence for Precision Psychiatry
Join us in Amsterdam—or virtually—for a pivotal 1.5-day meeting hosted by ECNP, dedicated to advancing the clinical application of Precision Psychiatry.
As part of ECNP’s Roadmap initiative to incorporate new scientific evidence on an ongoing basis into a biologically informed framework for mental disorders, this high-impact event will spotlight the urgent need to move from conceptual frameworks to real-world implementation.
Building on previous successful meetings exploring scientific foundations, methodological approaches, and biomarker-driven strategies, next year’s meeting will focus on how the field can transition toward precision psychiatry clinical trials. Key topics will include when and how mechanisms matter, how emerging technologies can improve the definition of patient populations, and whether artificial intelligence can support target identification and enrichment strategies.
The meeting will also examine how clinical trial design must evolve to enable biologically informed psychiatry that is clinically meaningful, interpretable, and ready for regulatory pathways. A central aim will be to integrate lessons learned from failed or non-replicated studies and explore how biological evidence can be incorporated into psychiatry while preserving the complexity and clinical relevance of mental disorders.
Why attend?
Precision psychiatry offers a transformative approach to understanding and treating mental illness—rooted in objective, biologically informed markers rather than symptom-based categories. This meeting will bring together all key stakeholders:
- Regulatory authorities
- Clinicians and researchers
- Industry leaders
- Health technology assessors
- Payers and policymakers
- Patient advocacy groups
Together, we will explore how to translate advances in biology, technology, and data science into clinically meaningful and implementable approaches for Precision Psychiatry.
Key themes include:
- Defining when biological mechanisms can improve clinical trial success
- Developing strategies for patient stratification and enrichment
- Leveraging AI and emerging technologies to identify targets and improve trial design
- Learning from failed and non-replicated studies
- Integrating biological evidence while maintaining clinical relevance
- Building a regulatory-ready pathway for precision psychiatry
Join us in Amsterdam and contribute to shaping the future of mental healthcare through science, innovation, and collaboration!
Committee
Meet the members of the Roadmap Meeting Programme Committee 2027.
Terms and conditions
For the terms and conditions, click here.
Past meeting
Check the previous meeting below: